{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:00:29Z","timestamp":1792839629356,"version":"4.5.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":896,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.jhep.2010.09.002","type":"journal-article","created":{"date-parts":[[2010,9,19]],"date-time":"2010-09-19T04:14:25Z","timestamp":1284869665000},"page":"374-385","source":"Crossref","is-referenced-by-count":486,"title":["Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue"],"prefix":"10.1016","volume":"54","author":[{"given":"Kirsten Muri","family":"Boberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger W.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon M.","family":"Hirschfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar W.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Schrumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2010.09.002_b0005","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1055\/s-2008-1068269","article-title":"A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis)","volume":"112","author":"Brunner","year":"1987","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jhep.2010.09.002_b0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2005-916322","article-title":"Overlap syndromes","volume":"25","author":"Beuers","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2010.09.002_b0015","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1053\/jhep.2001.23316","article-title":"Autoimmune overlap syndromes","volume":"33","author":"Woodward","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0020","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.3748\/wjg.14.3368","article-title":"Overlap syndromes among autoimmune liver diseases","volume":"14","author":"Rust","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.09.002_b0025","first-page":"1135","article-title":"Overlap syndromes","volume":"vol. 2","author":"Heathcote","year":"1999"},{"key":"10.1016\/j.jhep.2010.09.002_b0030","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: International Autoimmune Hepatitis Group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0035","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0045","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/0016-5085(94)90829-X","article-title":"Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?","volume":"107","author":"Colombato","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.09.002_b0050","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00001574-200205000-00007","article-title":"Autoimmune liver disease","volume":"18","author":"Czaja","year":"2002","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhep.2010.09.002_b0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.09.002_b0060","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.21074","article-title":"Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly","volume":"43","author":"Czaja","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0065","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2008-1040641","article-title":"Natural history, clinical features, and treatment of autoimmune hepatitis","volume":"4","author":"Czaja","year":"1984","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2010.09.002_b0075","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1089-3261(03)00092-8","article-title":"Autoimmune overlapping syndromes","volume":"7","author":"Poupon","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2010.09.002_b0080","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1053\/he.2000.5980","article-title":"Autoimmune hepatitis: the investigational and clinical challenges","volume":"31","author":"Czaja","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0085","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0090","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/gast.2001.24227","article-title":"Autoimmune hepatitis: clinical challenges","volume":"120","author":"Manns","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.09.002_b0095","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/0891693021000054101","article-title":"Frequency and significance of antibodies to soluble liver antigen\/liver pancreas in variant autoimmune hepatitis","volume":"35","author":"Czaja","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jhep.2010.09.002_b0100","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1478-3231.2009.01986.x","article-title":"Significance of antibodies to soluble liver antigen\/liver pancreas: a large French study","volume":"29","author":"Eyraud","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2010.09.002_b0105","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1055\/s-2001-12906","article-title":"Presence of SLA\/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)","volume":"126","author":"Kanzler","year":"2001","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jhep.2010.09.002_b0110","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals","volume":"29","author":"Lohse","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0115","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/0891693021000064272","article-title":"The hepatitic\/cholestatic \u201coverlap\u201d syndrome: an Italian experience","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jhep.2010.09.002_b0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1089-3261(02)00022-3","article-title":"The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants","volume":"6","author":"Carpenter","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2010.09.002_b0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0046-8177(72)80076-5","article-title":"Abnormal bile duct epithelium in chronic aggressive hepatitis and primary biliary cirrhosis","volume":"3","author":"Christoffersen","year":"1972","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jhep.2010.09.002_b0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0676.1993.tb00648.x","article-title":"The hepatitis-associated bile duct lesion","volume":"13","author":"Vyberg","year":"1993","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2010.09.002_b0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-0676.1984.tb00914.x","article-title":"Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology","volume":"4","author":"Ludwig","year":"1984","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2010.09.002_b0140","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/jhep.2001.27562","article-title":"Autoimmune hepatitis with incidental histologic features of bile duct injury","volume":"34","author":"Czaja","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0145","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1478-3231.2004.0924.x","article-title":"Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis","volume":"24","author":"Czaja","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2010.09.002_b0150","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","article-title":"Primary biliary cirrhosis","volume":"335","author":"Kaplan","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.09.002_b0155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"Management of cholestatic liver diseases","volume":"51","author":"EASL Clinical Practice Guidelines","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0160","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","article-title":"Management of primary biliary cirrhosis. The American association for the study of liver diseases practice guidelines","volume":"31","author":"Heathcote","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0165","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2005-916321","article-title":"Antinuclear antibodies in primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2010.09.002_b0170","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.cgh.2009.07.012","article-title":"Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease","volume":"7","author":"Milkiewicz","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0175","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0180","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.09.002_b0185","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/0016-5085(93)90160-E","article-title":"Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.09.002_b0190","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1440-1746.2006.04130.x","article-title":"Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial\/anti-M2 seropositive variant form of autoimmune hepatitis","volume":"21","author":"Farias","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0195","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/BF01296447","article-title":"Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis","volume":"31","author":"Kenny","year":"1986","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2010.09.002_b0200","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2249.2004.02332.x","article-title":"\u2018True\u2019 antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?","volume":"135","author":"Muratori","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhep.2010.09.002_b0205","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O\u2019Brien","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0016-5085(85)80141-4","article-title":"Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis","volume":"88","author":"Wiesner","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.09.002_b0215","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.510290444","article-title":"Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression","volume":"29","author":"Degott","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0220","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1572-0241.2002.05703.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system","volume":"97","author":"Talwalkar","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.09.002_b0225","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gut.21.10.870","article-title":"Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology","volume":"21","author":"Chapman","year":"1980","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2010.09.002_b0230","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broom\u00e9","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2010.09.002_b0235","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0240","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-125-7-199610010-00009","article-title":"The variant forms of autoimmune hepatitis","volume":"125","author":"Czaja","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2010.09.002_b0245","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0168-8278(92)90178-R","article-title":"Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis","volume":"14","author":"Perdigoto","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0250","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2008-1040541","article-title":"Hepatobiliary complications of inflammatory bowel disease","volume":"8","author":"Schrumpf","year":"1988","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2010.09.002_b0255","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.09.002_b0260","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.510230612","article-title":"Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis","volume":"23","author":"Boberg","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0265","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(00)80061-6","article-title":"Serum autoantibodies in patients with primary sclerosing cholangitis","volume":"32","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0270","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3748\/wjg.14.3781","article-title":"Autoantibodies in primary sclerosing cholangitis","volume":"14","author":"Hov","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.09.002_b0275","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/hep.1840060403","article-title":"Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis","volume":"6","author":"Ludwig","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0280","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1572-0241.2000.03292.x","article-title":"Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis","volume":"95","author":"Saarinen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.09.002_b0285","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0016-5085(76)80453-2","article-title":"Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome","volume":"71","author":"Geubel","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.09.002_b0290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00432159","article-title":"Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity","volume":"373","author":"Kloppel","year":"1977","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.jhep.2010.09.002_b0295","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(80)92397-1","article-title":"Serological classification of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies","volume":"2","author":"Berg","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2010.09.002_b0300","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02093820","article-title":"Validation of scoring system for diagnosis of autoimmune hepatitis","volume":"41","author":"Czaja","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2010.09.002_b0305","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0310","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0315","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jhep.2002.30902","article-title":"Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid","volume":"35","author":"Joshi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s005350300006","article-title":"A scoring system for primary biliary cirrhosis and its application for variant forms of autoimmune liver disease","volume":"38","author":"Yamamoto","year":"2003","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.09.002_b0325","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00042737-200406000-00012","article-title":"Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease","volume":"16","author":"Gheorghe","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0330","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1440-1746.2004.03372.x","article-title":"Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome","volume":"19","author":"Suzuki","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0335","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0399-8320(07)89323-7","article-title":"Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease","volume":"31","author":"Heurgu\u00e9","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jhep.2010.09.002_b0340","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2010.09.002_b0345","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejim.2008.12.011","article-title":"Transitions between variant forms of primary biliary cirrhosis during long-term follow-up","volume":"20","author":"Lindgren","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jhep.2010.09.002_b0350","first-page":"1009A","article-title":"Assessment of 479 patients with autoimmune liver diseases according to the IAIHG scoring system for autoimmune hepatitis does not support the contention of overlap syndromes as separate diagnostic entities","volume":"50","author":"Boberg","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0355","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ajg.2009.616","article-title":"Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis","volume":"105","author":"Neuhauser","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.09.002_b0360","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1478-3231.2007.01538.x","article-title":"Development of autoimmune hepatitis in primary biliary cirrhosis","volume":"27","author":"Gossard","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2010.09.002_b0365","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.21229","article-title":"Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis","volume":"44","author":"Poupon","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0370","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0168-8278(05)80394-0","article-title":"Autoimmune chronic active hepatitis responsive to immunosuppressive therapy evolving into a typical primary biliary cirrhosis syndrome: a case report","volume":"21","author":"Horsmans","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0375","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/BF02065530","article-title":"Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases","volume":"40","author":"Goodman","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2010.09.002_b0380","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0385","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hep.510260103","article-title":"Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation","volume":"26","author":"Kim","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0390","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0168-8278(96)80266-2","article-title":"Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis","volume":"24","author":"Gohlke","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0395","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2007-1007301","article-title":"A 39 year old man with chronic hepatitis","volume":"14","author":"Lawrence","year":"1994","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2010.09.002_b0400","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1572-0241.1998.224_a.x","article-title":"Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases","volume":"93","author":"McNair","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.09.002_b0405","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1007\/BF01296509","article-title":"Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis","volume":"37","author":"Rabinovitz","year":"1992","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2010.09.002_b0410","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0415","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1600-0641.2000.033004543.x","article-title":"High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis","volume":"33","author":"van Buuren","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0420","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.09.002_b0425","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/jhep.2002.37200","article-title":"Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome","volume":"36","author":"Abdo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0430","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MEG.0b013e3282e1c648","article-title":"Autoimmune hepatitis 2 years after the diagnosis of primary sclerosing cholangitis: an unusual overlap syndrome in a 17-year-old adolescent","volume":"20","author":"Mueller","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0435","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-102-5-581","article-title":"Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?","volume":"102","author":"Wee","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2010.09.002_b0440","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejim.2008.06.004","article-title":"High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis","volume":"20","author":"Olsson","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jhep.2010.09.002_b0445","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1385\/CRIAI:28:2:105","article-title":"Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis","volume":"28","author":"Schramm","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jhep.2010.09.002_b0450","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.23024","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study","volume":"50","author":"Lewin","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0455","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging","volume":"47","author":"Abdalian","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0460","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0016-5085(87)91082-1","article-title":"Primary sclerosing cholangitis in childhood","volume":"92","author":"El-Shabrawi","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.09.002_b0465","first-page":"1415","article-title":"Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis","volume":"22","author":"Wilschanski","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0470","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0029-1233529","article-title":"Autoimmune hepatitis in children: what is different from adult AIH?","volume":"29","author":"Mieli-Vergani","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2010.09.002_b0475","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S1542-3565(04)00396-9","article-title":"Diagnosing autoimmune hepatitis in children: is the International Autoimmune Hepatitis Group scoring system useful?","volume":"2","author":"Ebbeson","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0480","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/jhep.2003.50289","article-title":"Primary sclerosing cholangitis in children: a long-term follow-up study","volume":"38","author":"Feldstein","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0485","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1023\/A:1010620122567","article-title":"A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases","volume":"46","author":"Burak","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2010.09.002_b0490","first-page":"360","article-title":"Primary biliary cirrhosis-primary sclerosing cholangitis overlap syndrome","volume":"108","author":"Rubel","year":"1984","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jhep.2010.09.002_b0495","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-0676.1995.tb00690.x","article-title":"Granulomas in primary slerosing cholangitis","volume":"15","author":"Ludwig","year":"1995","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2010.09.002_b0500","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1740-2557-4-3","article-title":"The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis\/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders","volume":"4","author":"Papamichalis","year":"2007","journal-title":"J Autoimmune Dis"},{"key":"10.1016\/j.jhep.2010.09.002_b0505","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cgh.2010.03.004","article-title":"Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome","volume":"8","author":"Kuiper","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0510","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jhep.2004.06.001","article-title":"Genetics of autoimmune and viral liver diseases; understanding the issues","volume":"41","author":"Donaldson","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0515","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/hep.1840200133","article-title":"The molecular genetics of autoimmune liver disease","volume":"20","author":"Donaldson","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.09.002_b0520","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1023\/A:1020166605016","article-title":"Genetic bases of autoimmune hepatitis","volume":"47","author":"Czaja","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2010.09.002_b0525","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.3748\/wjg.v13.i41.5421","article-title":"Genetic epidemiology of primary sclerosing cholangitis","volume":"13","author":"Karlsen","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.09.002_b0530","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1023\/A:1005670111068","article-title":"Shared genetic risk factors in autoimmune liver disease","volume":"46","author":"Czaja","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2010.09.002_b0535","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.09.002_b0540","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.09.002_b0545","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/ajg.2009.126","article-title":"The serological profile of the autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome","volume":"104","author":"Muratori","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.09.002_b0550","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/10446670310001642159","article-title":"Characterization of a lipoyl domain-independent B-cell autoepitope on the human branched-chain acyltransferase in primary biliary cirrhosis and overlap syndrome with autoimmune hepatitis","volume":"10","author":"Csepregi","year":"2003","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jhep.2010.09.002_b0555","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","article-title":"Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome","volume":"44","author":"Chazouill\u00e8res","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0560","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00029330-200602010-00013","article-title":"Clinical features of the overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis: retrospective study","volume":"119","author":"Wu","year":"2006","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jhep.2010.09.002_b0565","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jhep.2009.01.020","article-title":"Autoimmune hepatitis in Italy: the Bologna experience","volume":"50","author":"Muratori","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0570","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/BF02064201","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A","volume":"40","author":"Duclos-Vall\u00e9e","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2010.09.002_b0575","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/gast.2002.31880","article-title":"Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients","volume":"122","author":"Corpechot","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.09.002_b0580","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2008.07.019","article-title":"Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment","volume":"135","author":"Huet","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.09.002_b0585","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.09.002_b0590","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/00365520310005172","article-title":"Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients","volume":"38","author":"Boberg","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.09.002_b0595","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0b013e318157c614","article-title":"Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"43","author":"L\u00fcth","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2010.09.002_b0600","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1586\/17474124.1.2.329","article-title":"Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases","volume":"1","author":"Silveira","year":"2007","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.09.002_b0605","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MPG.0b013e3181a1c265","article-title":"Autoimmune hepatitis","volume":"49","author":"Mieli-Vergani","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2010.09.002_b0610","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/gut.49.4.589","article-title":"Autoimmune hepatitis and its variant syndromes","volume":"49","author":"Ben-Ari","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2010.09.002_b0615","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1572-0241.2002.05699.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system","volume":"97","author":"Heathcote","year":"2002","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810008172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810008172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T18:28:47Z","timestamp":1559672927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827810008172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":123,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0168827810008172"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2010.09.002","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}